The role of the new beta-blockers in treating cardiovascular disease
about
sameAs
Nebivolol: a novel beta-blocker with nitric oxide-induced vasodilatationNebivolol: third-generation beta-blockadeBeta-blockers for hypertension.Rationale for nebivolol/valsartan combination for hypertension: review of preclinical and clinical data.Comparative effectiveness of 2 β-blockers in hypertensive patientsMechanisms of improved aortic stiffness by arotinolol in spontaneously hypertensive rats.Cardiovascular-related healthcare resource utilization and costs in patients with hypertension switching from metoprolol to nebivolol.Beta-blockers in the management of hypertension: focus on nebivolol.Detection and quantitation of β-blockers in plasma and urine.Cardio-selective beta-blocker: pharmacological evidence and their influence on exercise capacity.Antihypertensive Drugs and Male Sexual Dysfunction: A Review of Adult Hypertension Guideline Recommendations.Fixed-dose combination therapy of nebivolol and valsartan for the treatment of hypertension.Simultaneous Estimation of Nebivolol Hydrochloride and Valsartan using RP HPLCNebivolol reduces proteinuria and renal NADPH oxidase-generated reactive oxygen species in the transgenic Ren2 rat.Phenotypic differences in nebivolol metabolism and bioavailability in healthy volunteers.Effect of low sodium intake and β-blockade on renin synthesis and secretion in mice with unilateral ureteral ligation.Adding nebivolol to ongoing antihypertensive therapy improves blood pressure and response rates in patients with uncontrolled stage I-II hypertension.Beta-blockers: acting in the brain but healing the heart.
P2860
Q24681317-7D82028E-1B8E-4BD9-80F0-2D40D72B8A60Q28238369-B880AC3B-D5B2-4BA8-A9B2-68099BD1F5D2Q30238911-E52EF513-4D97-4CE0-865B-1DD3EB5A165FQ30491698-5BF8A529-E6A2-42E5-877E-71F1B7D3331EQ33997802-50F4A60E-798D-4477-A49F-E1A531606BDBQ35095540-EE1F4141-2B23-4422-888F-6ABAA9B63555Q35623864-7D9D97C4-149B-4B8F-9879-6F73C41A73F1Q37134471-77473494-386C-4BCB-9113-249229E88359Q37810249-5EB04175-01DA-4EAF-B419-E60270931EEBQ37978886-EB6FC919-B372-4CD4-BB92-27C3D67578FAQ38602936-85AEEA39-99B5-461C-A2AF-8FD0D222E205Q38778217-3BF76E3D-270A-4239-8230-021CF57B64A4Q39643542-5E2E0643-EDE2-4DAA-8B3C-1854100B4C28Q41896349-71032421-5894-4777-BFC5-517C2FABE5AAQ42731799-AE1D9CDE-0C12-4076-8169-D971D9CA8DCDQ42873283-F823DA05-BE20-441E-A484-FCB2D7717F6DQ46031238-A5F0EF1E-3DE6-49D5-9D7F-14FC18ED22DBQ49025875-9C0418B9-CFC1-45EB-AB9E-99457BB92713
P2860
The role of the new beta-blockers in treating cardiovascular disease
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
The role of the new beta-blockers in treating cardiovascular disease
@ast
The role of the new beta-blockers in treating cardiovascular disease
@en
The role of the new beta-blockers in treating cardiovascular disease
@nl
type
label
The role of the new beta-blockers in treating cardiovascular disease
@ast
The role of the new beta-blockers in treating cardiovascular disease
@en
The role of the new beta-blockers in treating cardiovascular disease
@nl
altLabel
The Role of the New β-Blockers in Treating Cardiovascular Disease
@en
prefLabel
The role of the new beta-blockers in treating cardiovascular disease
@ast
The role of the new beta-blockers in treating cardiovascular disease
@en
The role of the new beta-blockers in treating cardiovascular disease
@nl
P1476
The Role of the New β-Blockers in Treating Cardiovascular Disease
@en
The role of the new beta-blockers in treating cardiovascular disease
@en
P2093
Michael A Weber
P304
P356
10.1016/J.AMJHYPER.2005.09.009
P407
P577
2005-12-01T00:00:00Z